High Purity Pharmaceutical Intermediate: Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate CAS 161798-03-4 Manufacturer & Supplier

Discover a reliable source for high-quality Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate (CAS 161798-03-4). This critical pharmaceutical intermediate is essential for the synthesis of Febuxostat, a leading treatment for hyperuricemia and gout. We provide detailed specifications and competitive pricing for global procurement needs.

Get a Quote & Sample

Advantages of Sourcing Our Pharmaceutical Intermediates

Uncompromising Quality Control

Each batch of our Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate undergoes stringent quality checks to ensure it meets or exceeds industry standards, guaranteeing the reliability of your pharmaceutical synthesis.

Cost-Effective Procurement

We understand the importance of cost management in pharmaceutical manufacturing. By optimizing our production processes and supply chain, we offer competitive prices for this Febuxostat intermediate, making us an ideal supplier for your procurement needs.

Secure and Stable Supply Chain

With a production capacity of 1000kg/Month, we ensure a stable and uninterrupted supply of this vital pharmaceutical intermediate. Our logistics network guarantees timely delivery worldwide, making us a dependable manufacturer you can count on.

Applications and Significance

Pharmaceutical Synthesis

This compound serves as a fundamental building block in the complex synthesis pathways for active pharmaceutical ingredients (APIs), specifically vital for creating Febuxostat.

Febuxostat Production

Its primary application is as a key intermediate in the manufacturing of Febuxostat, a critical medication used globally to manage hyperuricemia and treat chronic gout by inhibiting xanthine oxidase.

Gout and Hyperuricemia Treatment

By facilitating the synthesis of Febuxostat, this intermediate plays an indirect but crucial role in improving the quality of life for patients suffering from gout and high uric acid levels.

Research and Development

Available in research quantities, it is also valuable for R&D laboratories exploring new synthetic routes or developing novel derivatives within the pharmaceutical and fine chemical sectors.